CGONCG Oncology, Inc.

$78.41

Who owns CGON

230 institutions reported holding CGON for 2026Q1, together 104% of the company, more than the 192 a quarter earlier.

230

Institutions reporting a position · as of 2026Q1 · up from 192 the quarter before

Shares held by institutions
88.1M

Shares held by institutions · 104% of the company · long US equity positions only, as reported on Form 13F

Reported value
$5.93B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
38%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
9
New positions
56
Positions exited
24
Added to
80
Reduced
58
Top 10 holdersof the company
60%
Institutional ownership by quarter, 2024Q1 to 2026Q1
QuarterFilersSharesReported value
2026Q123088.1M$5.93B
2025Q419282.6M$3.43B
2025Q317477.6M$3.13B
2025Q216075.9M$1.97B
2025Q114170.8M$1.74B
2024Q413966.2M$1.90B
2024Q312152.2M$1.96B
2024Q211143.3M$1.37B
2024Q19538.8M$1.70B
Largest reported holders, 2026Q1
HolderShares% of companyValue
RTW INVESTMENTS, LP7.0M8.3%$473M
T. Rowe Price Investment Management, Inc.6.7M8.0%$455M
VANGUARD GROUP INC6.7M7.9%$452M
Decheng Capital LLC6.4M7.5%$431M
WELLINGTON MANAGEMENT GROUP LLP5.4M6.4%$364M
BlackRock Inc.5.1M6.0%$343M
FMR LLC3.8M4.5%$255M
TCG Crossover Management, LLC3.7M4.3%$248M
PRICE T ROWE ASSOCIATES INC /MD/3.7M4.3%$247M
STATE STREET CORP2.6M3.1%$179M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…